Thomas F. Whayne

1.9k total citations
82 papers, 1.3k citations indexed

About

Thomas F. Whayne is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Thomas F. Whayne has authored 82 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 25 papers in Cardiology and Cardiovascular Medicine and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Thomas F. Whayne's work include Lipoproteins and Cardiovascular Health (23 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Pharmacology and Obesity Treatment (6 papers). Thomas F. Whayne is often cited by papers focused on Lipoproteins and Cardiovascular Health (23 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Pharmacology and Obesity Treatment (6 papers). Thomas F. Whayne collaborates with scholars based in United States, Canada and Brazil. Thomas F. Whayne's co-authors include Sibu P. Saha, James M. Felts, Debabrata Mukherjee, John W. Severinghaus, Patricia S. Otto, Petar Alaupovic, Eliot Schechter, D. K. Bhalla, Michael D. Curry and Elisa T. Lee and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Circulation Research.

In The Last Decade

Thomas F. Whayne

77 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas F. Whayne United States 20 385 331 297 267 170 82 1.3k
François Berthézène France 20 352 0.9× 472 1.4× 540 1.8× 243 0.9× 162 1.0× 36 1.6k
Célia Maria Cássaro Strunz Brazil 21 283 0.7× 552 1.7× 247 0.8× 191 0.7× 162 1.0× 91 1.5k
Hiroshi Takane Japan 23 261 0.7× 197 0.6× 211 0.7× 468 1.8× 173 1.0× 71 1.8k
Shin Irie Japan 24 375 1.0× 187 0.6× 246 0.8× 289 1.1× 124 0.7× 89 1.9k
Mercedes Muros de Fuentes Spain 13 198 0.5× 187 0.6× 402 1.4× 416 1.6× 205 1.2× 13 1.8k
Marek H Dominiczak United Kingdom 19 367 1.0× 170 0.5× 554 1.9× 298 1.1× 176 1.0× 108 1.6k
Constantine E. Kosmas United States 23 533 1.4× 501 1.5× 422 1.4× 254 1.0× 210 1.2× 57 1.6k
Kazuko Nakagawa Japan 32 454 1.2× 383 1.2× 339 1.1× 588 2.2× 189 1.1× 117 2.8k
Georgia Vogiatzi Greece 18 304 0.8× 504 1.5× 328 1.1× 515 1.9× 263 1.5× 83 2.0k
Sotirios Tsalamandris Greece 11 231 0.6× 308 0.9× 280 0.9× 305 1.1× 292 1.7× 43 1.5k

Countries citing papers authored by Thomas F. Whayne

Since Specialization
Citations

This map shows the geographic impact of Thomas F. Whayne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Whayne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Whayne more than expected).

Fields of papers citing papers by Thomas F. Whayne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F. Whayne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Whayne. The network helps show where Thomas F. Whayne may publish in the future.

Co-authorship network of co-authors of Thomas F. Whayne

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Whayne. A scholar is included among the top collaborators of Thomas F. Whayne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Whayne. Thomas F. Whayne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Whayne, Thomas F.. (2019). Hypertriglyceridemia: An Infrequent, Difficult-to-predict, Severe Metabolic and Vascular Problem Associated with Estrogen Administration. Current Vascular Pharmacology. 18(3). 254–261. 6 indexed citations
2.
Whayne, Thomas F. & Sibu P. Saha. (2019). Genetic Risk, Adherence to a Healthy Lifestyle, and Ischemic Heart Disease. Current Cardiology Reports. 21(1). 1–1. 21 indexed citations
3.
Whayne, Thomas F.. (2018). Non-Traditional Cardiovascular Risk Markers in the Era of Established Major Risk Factors and Multiple Guidelines. Current Vascular Pharmacology. 17(3). 270–277. 22 indexed citations
4.
Whayne, Thomas F. & Sibu P. Saha. (2018). Management Strategies for Noncardiac Surgery Following a Coronary Artery Event. Current Cardiology Reports. 20(1). 3–3. 2 indexed citations
5.
Whayne, Thomas F.. (2016). Prevention of Carotid Artery Atherosclerosis: What is the Evidence?. Angiology. 68(8). 661–668. 7 indexed citations
6.
Whayne, Thomas F., Sibu P. Saha, & Debabrata Mukherjee. (2016). Antioxidants in the Practice of Medicine; What Should the Clinician Know?. Cardiovascular & Haematological Disorders - Drug Targets. 16(1). 13–20. 19 indexed citations
7.
Whayne, Thomas F. & Debabrata Mukherjee. (2015). Unique Coronary Artery Disease Differences in Women as Related to Revascularization. Current Medicinal Chemistry. 22(31). 3597–3606. 8 indexed citations
8.
Whayne, Thomas F.. (2014). Epigenetics in the development, modification, and prevention of cardiovascular disease. Molecular Biology Reports. 42(4). 765–776. 49 indexed citations
9.
Saha, Sibu P., Thomas F. Whayne, S L McElroy, & Debabrata Mukherjee. (2013). Current Evidence for Antithrombotic Therapy after Peripheral Vascular Interventions. Current Vascular Pharmacology. 11(4). 507–513. 3 indexed citations
10.
Whayne, Thomas F. & Nilanjana Maulik. (2012). Nutrition and the healthy heart with an exercise boost. Canadian Journal of Physiology and Pharmacology. 90(8). 967–976. 17 indexed citations
11.
Whayne, Thomas F.. (2012). Assessment of Low-Density Lipoprotein Targets. Angiology. 64(6). 411–416. 6 indexed citations
12.
Whayne, Thomas F.. (2012). A Review of the Role of Anticoagulation in the Treatment of Peripheral Arterial Disease. International Journal of Angiology. 21(4). 187–194. 29 indexed citations
13.
Saha, Sibu P., Thomas F. Whayne, & Debabrata Mukherjee. (2011). Current Management of Peripheral Vascular Disease: Where is the Evidence?. Cardiovascular & Hematological Agents in Medicinal Chemistry. 9(2). 128–136. 6 indexed citations
14.
Whayne, Thomas F., et al.. (2011). Optimal Medical Therapy for Coronary Artery Disease in 2011 – Perspectives from the STICH Trial. Cardiovascular & Hematological Agents in Medicinal Chemistry. 9(4). 269–276. 3 indexed citations
15.
Whayne, Thomas F.. (2010). What Should Medical Practitioners Know about the Role of Alternative Medicines in Cardiovascular Disease Management?. Cardiovascular Therapeutics. 28(2). 106–123. 7 indexed citations
16.
Whayne, Thomas F.. (2009). Evaluation critique of state of the art dyslipidemia management in general and with a special emphasis on the Indian population.. PubMed. 59(3). 218–25. 5 indexed citations
17.
Saha, Sibu P. & Thomas F. Whayne. (2009). Cardiovascular care: a challenge for Kentucky.. PubMed. 107(8). 295–7.
18.
Wright, Christopher, et al.. (2005). Policosanol, an aliphatic alcohol sugarcane derivative: use in patients intolerant of or inadequately responsive to statin therapy. International Journal of Angiology. 13(4). 173–175. 9 indexed citations
19.
Whayne, Thomas F., James M. Felts, & Philip A. Harris. (1969). Effect of heparin on the inactivation of serum lipoprotein lipase by the liver in unanesthetized dogs. Journal of Clinical Investigation. 48(7). 1246–1251. 7 indexed citations
20.
Eger, Evelyn, et al.. (1968). The Circulatory Effects of the Addition of Nitrous Oxide to Halothane Anesthesia in Man. Anesthesiology. 29(1). 212–212. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026